Matches in SemOpenAlex for { <https://semopenalex.org/work/W4224581312> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W4224581312 endingPage "85" @default.
- W4224581312 startingPage "81" @default.
- W4224581312 abstract "To compare the efficacy and safety of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) for preventive or delayed treatment in neutropenia, completion rate of concurrent chemoradiotherapy and hospitalization rate in patients with esophageal squamous carcinoma during definitive concurrent chemoradiotherapy. A total of 70 patients with esophageal squamous carcinoma in Peking University Cancer Hospital from January 2019 to December 2020, who received PEG-rhG-CSF during concurrent chemoradiotherapy, were enrolled in this retrospective analysis. There were 32 patients in the preventive group, and 38 patients in the delayed group. The incidence of neutropenia, completion rate of concurrent chemoradiotherapy and neutropenia-related hospitalization rate were compared between PEG-rhG-CSF preventive group and delayed group. The incidence of severe neutropenia (Grades 3–4) in all patients was 31.4%. Comparison between preventive group and delayed group showed that the incidence of severe neutropenia was 6.3% and 39.4% (χ2 = 10.428, P = 0.001), respectively. In preventive group, the incidence of severe neutropenia was 3.7% and 20.0%, respectively, for primary prevention and secondary prevention of PEG-rhG-CSF (χ2 = 12.321, P = 0.001). The completion rate of concurrent chemoradiotherapy was 93.8% in the preventive group and 63.2% in the delayed group (χ2 = 9.220, P = 0.002). The incidence of treatment interruption was 25.7% in the whole group, 12.5% in the preventive group and 36.8% in the delayed group (χ2 = 5.389, P = 0.020). Seven patients (7/70, 10.0%) were hospitalized and treated with intravenous antibiotics for neutropenia, including 1 in the preventive group and 6 in the delayed group (P = 0.078). Prophylactic use of PEG-rhG-CSF during concurrent chemoradiotherapy for patients with esophageal squamous carcinoma can effectively reduce the incidence of neutropenia, ensure the safety of treatment, and improve the completion rate of concurrent chemoradiotherapy." @default.
- W4224581312 created "2022-04-27" @default.
- W4224581312 creator A5005038693 @default.
- W4224581312 creator A5017330670 @default.
- W4224581312 creator A5030238533 @default.
- W4224581312 creator A5052086393 @default.
- W4224581312 creator A5063738931 @default.
- W4224581312 creator A5069262441 @default.
- W4224581312 creator A5072910261 @default.
- W4224581312 creator A5073436439 @default.
- W4224581312 creator A5078550219 @default.
- W4224581312 date "2022-06-01" @default.
- W4224581312 modified "2023-10-16" @default.
- W4224581312 title "A retrospective study of pegylated recombinant human granulocyte colony-stimulating factor (PEG-rhG-CSF) in preventing neutropenia during definitive concurrent chemoradiotherapy in patients with esophageal squamous carcinoma" @default.
- W4224581312 cites W1900393559 @default.
- W4224581312 cites W1966875672 @default.
- W4224581312 cites W1986783484 @default.
- W4224581312 cites W2083336892 @default.
- W4224581312 cites W2125919881 @default.
- W4224581312 cites W2144263975 @default.
- W4224581312 cites W2151645021 @default.
- W4224581312 cites W2152939220 @default.
- W4224581312 cites W2156138108 @default.
- W4224581312 cites W2163882380 @default.
- W4224581312 cites W2999700331 @default.
- W4224581312 cites W3126845260 @default.
- W4224581312 cites W4210982437 @default.
- W4224581312 cites W4236554935 @default.
- W4224581312 cites W4251656587 @default.
- W4224581312 cites W4361808197 @default.
- W4224581312 doi "https://doi.org/10.1016/j.radmp.2022.04.002" @default.
- W4224581312 hasPublicationYear "2022" @default.
- W4224581312 type Work @default.
- W4224581312 citedByCount "0" @default.
- W4224581312 crossrefType "journal-article" @default.
- W4224581312 hasAuthorship W4224581312A5005038693 @default.
- W4224581312 hasAuthorship W4224581312A5017330670 @default.
- W4224581312 hasAuthorship W4224581312A5030238533 @default.
- W4224581312 hasAuthorship W4224581312A5052086393 @default.
- W4224581312 hasAuthorship W4224581312A5063738931 @default.
- W4224581312 hasAuthorship W4224581312A5069262441 @default.
- W4224581312 hasAuthorship W4224581312A5072910261 @default.
- W4224581312 hasAuthorship W4224581312A5073436439 @default.
- W4224581312 hasAuthorship W4224581312A5078550219 @default.
- W4224581312 hasBestOaLocation W42245813121 @default.
- W4224581312 hasConcept C120665830 @default.
- W4224581312 hasConcept C121332964 @default.
- W4224581312 hasConcept C126322002 @default.
- W4224581312 hasConcept C141071460 @default.
- W4224581312 hasConcept C2776694085 @default.
- W4224581312 hasConcept C2777063308 @default.
- W4224581312 hasConcept C2777767877 @default.
- W4224581312 hasConcept C2778424827 @default.
- W4224581312 hasConcept C61511704 @default.
- W4224581312 hasConcept C71924100 @default.
- W4224581312 hasConcept C90924648 @default.
- W4224581312 hasConceptScore W4224581312C120665830 @default.
- W4224581312 hasConceptScore W4224581312C121332964 @default.
- W4224581312 hasConceptScore W4224581312C126322002 @default.
- W4224581312 hasConceptScore W4224581312C141071460 @default.
- W4224581312 hasConceptScore W4224581312C2776694085 @default.
- W4224581312 hasConceptScore W4224581312C2777063308 @default.
- W4224581312 hasConceptScore W4224581312C2777767877 @default.
- W4224581312 hasConceptScore W4224581312C2778424827 @default.
- W4224581312 hasConceptScore W4224581312C61511704 @default.
- W4224581312 hasConceptScore W4224581312C71924100 @default.
- W4224581312 hasConceptScore W4224581312C90924648 @default.
- W4224581312 hasIssue "2" @default.
- W4224581312 hasLocation W42245813121 @default.
- W4224581312 hasOpenAccess W4224581312 @default.
- W4224581312 hasPrimaryLocation W42245813121 @default.
- W4224581312 hasRelatedWork W2017298652 @default.
- W4224581312 hasRelatedWork W2037592227 @default.
- W4224581312 hasRelatedWork W2061928026 @default.
- W4224581312 hasRelatedWork W2102925359 @default.
- W4224581312 hasRelatedWork W2114989931 @default.
- W4224581312 hasRelatedWork W2120457371 @default.
- W4224581312 hasRelatedWork W2361045318 @default.
- W4224581312 hasRelatedWork W2366109111 @default.
- W4224581312 hasRelatedWork W2426299259 @default.
- W4224581312 hasRelatedWork W4366111355 @default.
- W4224581312 hasVolume "3" @default.
- W4224581312 isParatext "false" @default.
- W4224581312 isRetracted "false" @default.
- W4224581312 workType "article" @default.